Table 3 SNAP-25 rs353050 genotype distribution of the individuals enrolled in the study (overall and severely sarcopenic patient undergoing rehabilitation in which circulatory miRNAs were analyzed)
SNAP-25 rs363050* | Sarcopenic patients | Healthy controls |
|---|---|---|
Overall group | n. 177 | n. 181 |
 AA** | 71 (40%) | 48 (27%) |
 AG | 73 (41%) | 109 (60%) |
 GG | 33 (19%) | 24 (13%) |
Severely sarcopenic patients undergoing rehabilitation | n. 45 | n. 44 |
 AA | 17 (38%) | 15 (33%) |
 AG | 22 (49%) | 25 (57%) |
 GG | 6 (13%) | 4 (10%) |